Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis

Clinical Toxicology

Volumn 45, Issue 3, 2007, Pages 295-298

  García Algar, Óscar ^a,b   López Vílchez, M Ángeles ^a   Martín, Itziar ^a   Mur, Antonio ^a,b   Pellegrini, Manuela ^c   Pacifici, Roberta ^c   Rossi, Silvia ^c   Pichini, Simona ^c  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Alprazolam; Drug testing; Neonatal sepsis; Neonatal withdrawal syndrome; Prenatal exposure

Indexed keywords

ALPRAZOLAM; AMPICILLIN; GENTAMICIN; OXYGEN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG HAIR LEVEL; DRUG URINE LEVEL; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; LONG TERM EXPOSURE; MALE; MECONIUM; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN SEPSIS; OXYGEN THERAPY; PLACENTA; PRENATAL DRUG EXPOSURE; STREPTOCOCCUS AGALACTIAE; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION; WITHDRAWAL SYNDROME;

ADULT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETAL BLOOD; HAIR; HUMANS; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MECONIUM; NEONATAL ABSTINENCE SYNDROME; OXYGEN INHALATION THERAPY; PLACENTA; PREGNANCY; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SUBSTANCE ABUSE DETECTION; TREATMENT OUTCOME; URINE;

STREPTOCOCCUS AGALACTIAE;

EID: 34047123222     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650601072191     Document Type: Article

References (20)

1. Soderpalm B. Pharmacology of the benzodiazepines; with special emphasis on alprazolam. Acta Psychiatr Scand Suppl 1987; 335:39-46.
2. Garzone PD, Kroboth PD. Pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 1989; 16:337-364.
3. Alprazolam datasheet. (Accessed October 2005, at www.pfizer.com/pfizer/ download/uspi_xanax_xr.pdf )
4. Barry WS, St Clair SM. Exposure to benzodiazepine in utero. Lancet 1987; 1:1436-1437.
5. St Clair SM, Schirmer RG. First-trimester exposure to alprazolam. Obstet Gynecol 1992; 80:843-846.
6. Eros E, Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2002; 101:147-154.
7. Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 2002; 53:39-49.
8. Johnson KA, Jones KL, Chambres CD, Dick L, Felix R. Pregnancy outcome in women exposed to non-Valium benzodiazepines. Abstract. Reprod Toxicol 1995; 9:585.
9. Jaiswal AK. Effect of prenatal alprazolam exposure on anxiety patterns in rat offspring. Indian J Exp Biol 2002; 40:35-39.
10. Cannizzaro C, Martire M, Steardo L, Cannizzaro E, Gagliano M, Mineo A, Provenzano G. Prenatal exposure to diazepam and alprazolam, but not to zolpidem, affects behavioural stress reactivity in handling-naive and handling-habituated adult male rat progeny. Brain Res 2002; 953:170-180.
11. Ornoy A, Arnon J, Shechtman S, Moerman L, Lukashova I. Is benzodiazepine use during pregnancy really teratogenic? Reprod Toxicol 1998; 12:511-515.
12. Kaltenbach K, Finnegan LP. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol 1986; 8:353-355.
13. García-Algar O, Puig C, Méndez C, Vall O, Pacifici R, Pichini S. Neonatal nicotine withdrawal syndrome. J Epidemiol Community Health 2001; 55:687-688.
14. Pichini S, Puig C, Zuccaro P, Marchei E, Pellegrini M, Murillo J, Vall O, Pacifici R, Garcia-Algar O. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project" Forensic Sci Int 2005; 153:59-65.
15. Garcia-Algar O, Vall O, Alameda F, Puig C, Pellegrini M, Pacifici R, Pichini S. Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes. Arch Dis Child Fetal Neonatal Ed 2005; 90:F276-F277.
16. Cirimele V, Kintz P, Ludes B. Screening for forensically relevant benzodiazepines in human hair by gas chromatography-negative ion chemical ionization-mass spectrometry. J Chromatogr B Biomed Sci Appl 1997; 700:119-129.
17. Rurak DW, Wright MR, Axelson JE. Drug disposition and effects in the fetus. J Dev Physiol 1991; 15:33-44.
18. Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ. The relationship of alprazolam dose to steady-state plasma concentrations. J Clin Psychopharmacol 1990; 10:27-32.
19. Segura M, Barbosa J, Torrens M, Farre M, Castillo C, Segura J, de la Torre R. Analytical methodology for the detection of benzodiazepine consumption in opioid-dependent subjects. J Anal Toxicol 2001; 25:130-136.
20. Anderson PO, McGuire GG. Neonatal alprazolam withdrawal - possible effects of breast feeding. DICP. 1989; 23:614.